A prolonged complete response in a patient with BRAF-mutated melanoma stage IV treated with the MEK1/2 inhibitor selumetinib (AZD6244)

标题
A prolonged complete response in a patient with BRAF-mutated melanoma stage IV treated with the MEK1/2 inhibitor selumetinib (AZD6244)
作者
关键词
-
出版物
ANTI-CANCER DRUGS
Volume 23, Issue 7, Pages 761-764
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2012-01-31
DOI
10.1097/cad.0b013e328350737d

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now